IN8bio, Inc. (INAB)
1.44
-0.01
(-0.69%)
USD |
NASDAQ |
Apr 17, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
IN8bio Total Assets (Quarterly) : 32.28M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | 61.37M |
| Calidi Biotherapeutics, Inc. | 8.857M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.724M |
| Shareholders Equity (Quarterly) | 27.56M |
| Debt to Equity Ratio | 0.101 |
| Current Ratio | 8.82 |
| Net Debt Paydown Yield | 5.06% |